Skip to content Skip to main menu Skip to utility menu

Drug safety notice: Hyoscine hydrobromide patches

April 5, 2024

There have been a small number of reports of serious and life-threatening anticholinergic side
effects associated with hyoscine hydrobromide patches, particularly when used outside the
licence. Healthcare professionals, patients, parents, and carers should be aware of the signs
and symptoms of serious side effects and the need to seek medical help if they occur.

For advice and solutions please seeĀ Safety Notice – Hypscine ButylBromide 1.5mg (Scopoderm) Patches

For more information please contact the pharmacy department on ext. 5263/3783.